MedPath

D-794

Generic Name
D-794

Clinical Study to Evaluate Drug-drug Interaction and Safety After Co-administration of D352 and D794 in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Dyslipidemia
Interventions
First Posted Date
2025-01-06
Last Posted Date
2025-05-21
Lead Sponsor
Chong Kun Dang Pharmaceutical
Target Recruit Count
40
Registration Number
NCT06758661
Locations
🇰🇷

H Plus Yangji Hospital, Gwanak-gu, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath